Evidence map›Paper›PMID 23225637›Full record

ArticleChembiochem : a European journal of chemical biology2013

A fluorescence-based assay for p38α recruitment site binders: identification of rooperol as a novel p38α kinase inhibitor.

Jing Li, Tamer S Kaoud, Jake LeVieux, Brad Gilbreath, Swapna Moharana, Kevin N Dalby, Sean M Kerwin

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Preparation and Utility ofMolecules (Basel, Switzerland) · 2019
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jing LiDepartment of Cell Biology, Harvard Medical School, 240 Longwood Ave, Boston, MA 02115, USA.
Tamer S Kaoud
Jake LeVieux
Brad Gilbreath
Swapna Moharana
Kevin N Dalby
Sean M Kerwin
The University of Texas at Austin · USHarvard University · US

Funding

Mechanism and Specificity of MAP KinasesR01GM059802 · NIGMS · UNIVERSITY OF TEXAS AUSTIN · PI DALBY, KEVIN N · 2001 to 2011
$2.3M
NIGMS NIH HHS GM59802NIGMS NIH HHS R01 GM059802
6 · The paper itself

Abstract

A new p38α inhibitor: Using a D-recruitment site (DRS) probe for p38α which exploits covalent interaction with Cys119 and alkyne-azide "click" chemistry to identify small molecules that recognize the p38α DRS, the anti-inflammatory natural product rooperol was identified as a novel p38α inhibitor.

Indexed as

Binding SitesCatecholsDrug Evaluation, PreclinicalImidazolesModels, Molecularp38 Mitogen-Activated Protein KinasesPhosphoproteinsProtein BindingProtein ConformationProtein Kinase InhibitorsSpectrometry, FluorescenceTemperatureCatecholsImidazolesp38 Mitogen-Activated Protein KinasesPhosphoproteinsProtein Kinase Inhibitorsrooperol

Identifiers

PMID23225637
PMCPMC3775607
OpenAlexW2056106333

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.